Transduction of Long-Term and Mobilized Peripheral Blood-Derived NOD/SCID Repopulating Cells by Foamy Virus Vectors
- 1 January 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 15 (1) , 87-92
- https://doi.org/10.1089/10430340460732481
Abstract
Foamy virus (FV) vectors are a promising gene delivery system for use in hematopoietic stem cell gene therapy. Previous FV vector marking studies in the NOD/SCID xenotransplantation model used umbilical cord blood (UCB)-derived SCID repopulating cells (SRCs) that were assayed 5-10 weeks posttransplantation. We now report efficient FV vector transduction (>65%) of UCB-derived primitive, long-term SRCs engrafted for 18 weeks. In addition, we evaluated gene transfer into mobilized peripheral blood (MPB)-derived SRCs by improved, deleted FV vectors containing minimal cis-acting sequences and packaged by split helper constructs that would be appropriate for use in clinical trials. When used at a multiplicity of infection of 1 in a 10-hr transduction protocol, these improved vectors transduced 34% of engrafted MPB-derived SRCs.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of Three Retroviral Vector Systems for Transduction of Nonobese Diabetic/Severe Combined Immunodeficiency Mice Repopulating Human CD34+Cord Blood CellsHuman Gene Therapy, 2003
- Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectorsProceedings of the National Academy of Sciences, 2002
- Improved Primate Foamy Virus Vectors and Packaging ConstructsJournal of Virology, 2002
- Differential long-term and multilineage engraftment potential from subfractions of human CD34+cord blood cells transplanted into NOD/SCID miceProceedings of the National Academy of Sciences, 2002
- [37] Gene transfer with foamy virus vectorsPublished by Elsevier ,2002
- Differential Transduction Efficiency of SCID-Repopulating Cells Derived from Umbilical Cord Blood and Granulocyte Colony-Stimulating Factor-Mobilized Peripheral BloodHuman Gene Therapy, 2001
- Helper-Free Foamy Virus VectorsHuman Gene Therapy, 1998
- No Evidence of Antibody to Human Foamy Virus in Widespread Human PopulationsAIDS Research and Human Retroviruses, 1996
- Markers of Foamy Virus Infections in Monkeys, Apes, and Accidentally Infected Humans: Appropriate Testing Fails to Confirm Suspected Foamy Virus Prevalence in HumansAIDS Research and Human Retroviruses, 1995
- At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cellsJournal of Molecular Biology, 1987